Entero Healthcare Solutions Limited (NSE:ENTERO)

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Trading of Pharmaceutical and Surgical Products	65.91B	50.96B	39.22B	33.00B	25.22B
Trading of Pharmaceutical and Surgical Products Growth	29.35%	29.92%	18.85%	30.85%	42.24%
Total	65.91B	50.96B	39.22B	33.00B	25.22B
Total Growth	29.35%	29.92%	18.85%	30.85%	42.24%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
India	65.91B	50.96B	39.22B	33.00B	-
India Growth	29.35%	29.92%	18.85%	-	-
Total	65.91B	50.96B	39.22B	33.00B	-
Total Growth	29.35%	29.92%	18.85%	-	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 15, 2026

Data Sources Report a data error